Micron Technology Poised for Growth On Strong AI Demand As Industry Enters The Most Significant Memory Cycle: Analyst

/ / Technology /

Rosenblatt analyst Hans Mosesmann reiterated Micron Technology Inc (NASDAQ:MU) with a Buy and a $140 price target. The analyst expects Micron to deliver a beat and raise on Wednesday, March 20, on AI-driven segment demand, a bottoming in the broader markets (recovery in the second half of calendar year 2024) amid the industry’s disciplined supply memory posture. As the industry enters the most significant memory cycle, the setup is a narrative that will be fed this week at Nvidia Corp’s (NASDAQ:NVDA) GPU Technology Conference (GTC), given that AI compute platforms cannot scale without DRAM content and high-performance HBM, he said.

Micron Technology Poised for Growth On Strong AI Demand As Industry Enters The Most Significant Memory Cycle: Analyst Read Post »

Lululemon’s Fourth-Quarter Print Has Slight Negative Bias, Soft First-Quarter Trends May Drive Volatility, UBS Says

/ / Consumer Discretionary /

Lululemon Athletica (LULU) has a slight negative bias heading into the March 21 fourth-quarter print with solid holiday trends previously discussed by management, but soft first-quarter sales could lead to volatility after the event, UBS said. The brokerage is guiding for revenue growth of about 16% to $3.22 billion in the fourth quarter, slightly above the consensus view of $3.19 billion. Its adjusted earnings per share target of $5.02 is also above the Street’s view of $5, Monday’s emailed note showed. “We anticipate that the international region will be the primary driver of sales growth as it benefits from ongoing unit expansion and recovery of the Greater China region,” UBS analysts including Jay Sole and Mauricio Serna wrote. Lululemon demand likely remained robust in the quarter that included the key holiday shopping period, they said, with management commentary previously suggesting such a scenario. UBS is modeling sales growth of 10%

Lululemon’s Fourth-Quarter Print Has Slight Negative Bias, Soft First-Quarter Trends May Drive Volatility, UBS Says Read Post »

Nvidia Introduces Latest GPU, AI Supercomputer, Networking Switches

/ / Technology /

Nvidia (NVDA) on Monday introduced its latest graphics processing unit, artificial intelligence supercomputer DGX SuperPOD and a new wave of networking switches. The company said its Blackwell GPU will enable organizations to run generative AI at up to 25 times less cost and energy consumption compared with its predecessor. The DGX SuperPOD, powered by NVIDIA GB200 Grace Blackwell Superchips, will be used for superscale generative AI training and inference workloads, the company said. The new networking switches, the NVIDIA Quantum-X800 InfiniBand and NVIDIA Spectrum X800 Ethernet, are optimized for trillion-parameter GPU computing and AI infrastructure, the company said. Shares of Nvidia fell 1% in recent after-hours trading.

Nvidia Introduces Latest GPU, AI Supercomputer, Networking Switches Read Post »

KLA Corp Reaffirms Q3 Revenue Guidance Range Of $2.3B, +/- $125M, Est $2.313B; Cuts Adj EPS Outlook From $5.26 +/- $0.60 Range To $4.83 +/- $0.60 Range, Est $5.31

/ / Technology /

KLA Corp Reaffirms Q3 Revenue Guidance Range Of $2.3B, +/- $125M, Est $2.313B; Cuts Adj EPS Outlook From $5.26 +/- $0.60 Range To $4.83 +/- $0.60 Range, Est $5.31。

KLA Corp Reaffirms Q3 Revenue Guidance Range Of $2.3B, +/- $125M, Est $2.313B; Cuts Adj EPS Outlook From $5.26 +/- $0.60 Range To $4.83 +/- $0.60 Range, Est $5.31 Read Post »

Microsoft: Announces Collaboration With NVIDIA to Accelerate Healthcare and Life Sciences Innovation With Advanced Cloud, AI and Accelerated Computing Capabilities

/ / Technology /

Microsoft: Announces Collaboration With NVIDIA to Accelerate Healthcare and Life Sciences Innovation With Advanced Cloud, AI and Accelerated Computing Capabilities。

Microsoft: Announces Collaboration With NVIDIA to Accelerate Healthcare and Life Sciences Innovation With Advanced Cloud, AI and Accelerated Computing Capabilities Read Post »

FedEx and Amazon Discussed Partnership as Competition for Returning Packages Intensifies

/ / Industrials /

By Esther Fung and Dana Mattioli After a high-profile split, FedEx and Amazon.com have explored doing more business with each other. The two companies last year discussed FedEx accepting returns of Amazon packages at its retail locations, bringing the delivery giant a share of the business, according to a person familiar with the matter. Amazon has partnerships with a number of companies, including FedEx rival United Parcel Service, to handle the millions of returns it has annually. The two sides didn’t reach a deal, but the developments come as FedEx has sought to boost parcel volumes amid an industry slump and Amazon seeks to improve the experience its customers have in returning items. The talks with FedEx happened last spring, around the same time that Amazon introduced a fee for some customers who bring their returns to UPS stores. In October, UPS signed a $465 million deal to buy Happy

FedEx and Amazon Discussed Partnership as Competition for Returning Packages Intensifies Read Post »

Pfizer to Cut Stake in Haleon

/ / Health Care /

By Elena Vardon Pfizer plans to sell a stake in Haleon currently valued at around 2 billion pounds ($2.55 billion), trimming its ownership in the consumer-healthcare business for the first time since its listing. The pharmaceutical giant intends to reduce its stake in Haleon to 24% from 32% currently, Haleon said Monday. With the move, Pfizer follows U.K. drugmaker GSK, which has been offloading its initial 12.9% shareholding in the company in recent months and now owns a 4.2% stake. This comes at a time of intense merger-and-acquisition activity in the pharmaceutical industry, which has seen big companies snapping up smaller biotechnology businesses. Haleon–which houses Sensodyne toothpaste and Aquafresh mouthwash as well as over-the-counter medicines Panadol and Advil–also agreed to buy back shares valued at GBP315 million from Pfizer at the same price as the public offer’s. The offer price will be determined via an accelerated bookbuild offering process which

Pfizer to Cut Stake in Haleon Read Post »

Scroll to Top